Analyst Ratings for IMS Health Holdings Inc (IMS)Updated: 2016-10-01
IMS was given price targets by several analysts. The most optimistic analyst gave a price target of 34, implying a possible profit of 8.49 percent. The minimum price target given was 25, which equates to a potential downside of -20.23 percent. It is crucial to not blindly accept any price targets or stock ratings, because many analysts have it in their best interest to give positive coverage of certain stocks.
In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is 2.78 percent. On the other hand, earnings estimates for the fiscal year have been revised upwards by 0 percent, as compared to a month ago. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.91 percent.
Another thing investors often look at is the level of agreement among analysts' revisions. Over the past month, 0 analysts increased their quarterly estimates, while 0 analysts made negative revisions. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.
IMS has an estimated earnings growth rate of 277.44 percent as forecasted by analysts. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. People often look for the PEG ratio to be under 1, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of IMS is 0.27.
IMS has traded between a high of 31.59 and a low of 22.36 over the past year. Today's price is 40.16 percent above the 52-week low, and 0.79 percent below the high. IMS has a price/earnings ratio of 75.45. Investors typically compare the P/E ratio to a company's peers in the industry. The IMS value stock report compares IMS to some of its peers using value stock charts. The stock has a market capitalization of $10.59 billion. IMS is estimated to release their earnings results for the quarter on 2016-10-27, days from today.